BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shoaei SD, Sali S, Karamipour M, Riahi E. Non-invasive histologic markers of liver disease in patients with chronic hepatitis B. Hepat Mon 2014;14:e14228. [PMID: 24693307 DOI: 10.5812/hepatmon.14228] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rahimkhani A, Haghighat S, Noorbazargan H, Mahdavi M. Improvement of hepatitis B vaccine to induce IFN-γ cytokine response: A new formulation. Microb Pathog 2021;160:105184. [PMID: 34508828 DOI: 10.1016/j.micpath.2021.105184] [Reference Citation Analysis]
2 Öznur M, Topçu B, Çelikkol A. Predictive value of noninvasive indices in chronic hepatitis B virus-related fibrosis. Eur J Gastroenterol Hepatol 2021;33:577-82. [PMID: 33657603 DOI: 10.1097/MEG.0000000000002045] [Reference Citation Analysis]
3 Savoji MA, Sereshgi MMA, Ghahari SMM, Asgarhalvaei F, Mahdavi M. Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses. Int Immunopharmacol 2021;96:107599. [PMID: 33848910 DOI: 10.1016/j.intimp.2021.107599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Osmani F, Azarkar G. Fitting logistic regression models to assess vitamin D deficiency with clinical parameters in chronic hepatitis B patients. Infect Dis Model 2021;6:612-7. [PMID: 33898881 DOI: 10.1016/j.idm.2021.03.008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Wan M, Xu H, Li D, Wang L, Li X. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI). Medicine (Baltimore) 2021;100:e24723. [PMID: 33578617 DOI: 10.1097/MD.0000000000024723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ben Ayed H, Koubaa M, Yaich S, Rekik K, Ben Jemaa T, Maaloul I, Marrekchi C, Damak J, Ben Jemaa M. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Med Mal Infect 2019;49:607-15. [PMID: 30871816 DOI: 10.1016/j.medmal.2019.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Liao R, Li D, Du C, Li M. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy. J Gastrointest Surg 2018;22:1679-87. [DOI: 10.1007/s11605-018-3810-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
8 Hong MZ, Ye L, Jin LX, Ren YD, Yu XF, Liu XB, Zhang RM, Fang K, Pan JS. Noninvasive scoring system for significant inflammation related to chronic hepatitis B. Sci Rep 2017;7:43752. [PMID: 28281521 DOI: 10.1038/srep43752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
9 Koksal AR, Alkim H, Boga S, Ergun M, Bayram M, Ozguven BY, Alkim C. Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better? Am J Ther. 2016;23:e429-e438. [PMID: 25650531 DOI: 10.1097/mjt.0000000000000203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
10 Liu Y, Wang Z, Cao Y, Zhang G, Chen W, Jiang C. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary & Pancreatic Diseases International 2016;15:266-74. [DOI: 10.1016/s1499-3872(16)60094-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
11 Peng J, Cai S, Yu T, Chen Y, Zhu Y, Sun J. Aspartate aminotransferase to platelet ratio index – a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues. Scandinavian Journal of Clinical and Laboratory Investigation 2016;76:133-42. [DOI: 10.3109/00365513.2015.1125013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
12 Jia W, Qi X, Ji YY, Xun YH, Wang H, Zhang WH, Yang JH, Wang JY, Zhu HX, Mao RC, Zhang JM. Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China. Hepat Mon 2015;15:e29183. [PMID: 26322110 DOI: 10.5812/hepatmon.29183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Mohamadkhani A, Bastani F, Khorrami S, Ghanbari R, Eghtesad S, Sharafkhah M, Montazeri G, Poustchi H. Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection. Hepat Mon. 2015;15:e28315. [PMID: 26288634 DOI: 10.5812/hepatmon.28315v2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
14 Xu WS, Qiu XM, Ou QS, Liu C, Lin JP, Chen HJ, Lin S, Wang WH, Lin SR, Chen J. Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B. Medicine (Baltimore). 2015;94:e612. [PMID: 25761184 DOI: 10.1097/md.0000000000000612] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
15 Rezaei M, Hosseini SN, Khavari-Nejad RA, Najafi F, Mahdavi M. Fast antibody responses by immuno-targeting and nanotechnology strategies versus HBsAg vaccine. Iran J Basic Med Sci 2021;24:545-50. [PMID: 34094038 DOI: 10.22038/IJBMS.2021.52715.11896] [Reference Citation Analysis]